R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 7/8/20

5 months ago By Josh Neil
  • Share on

  • Facebook
  • Linkedin
Proventa International Weekly News

In the news this week, vaccine deals are afoot on either side of the Atlantic: both the U.K. and U.S. governments have signed deals with Sanofi and GSK for doses of their COVID-19 vaccine, while the UK has also requested pharma companies begin stockpiling drugs for the period immediately post-Brexit. In other news, more potential COVID drugs appear on the horizon, though the price for current candidates is seen to vary wildly between companies.

UK SIGNS COVID-19 VACCINE DEAL WITH GSK AND SANOFI – The UK government has signed a fourth deal on coronavirus vaccines, this time securing 60 million doses of an experimental treatment, The government also secured another 90 million doses of two other promising vaccines. The GSK/Sanofi vaccine is based on the recombinant protein-based technology Sanofi uses to produce a flu vaccine. Regulatory approval for the vaccine could be reached halfway through 2021, if all trials are successful. 

UK GOVERNMENT CALLS FOR POST-BREXIT DRUG STOCKPILES – The UK government has requested that pharma companies stockpile at least six weeks’ worth of drugs in readiness for the full Brexit transition. This reserve would, it said, provide a buffer against the disruption caused by COVID-19. 

U.S. GOVERNMENT SANOFI/GSK PAYS $2.1 BILLION FOR COVID VACCINE DOSES – The Trump administration has committed more than $2 billion for an initial 100 million doses of Sanofi/GSK’s potential COVID-19 vaccine. This comes as part of its Operation Warp Speed vaccine development initiative, and will accelerate manufacturing of the vaccine. 

In other news:

R&D
Gilead urged to study potential COVID-19 treatment showing promise in cats 

Clinical Trials
Eli Lilly’s COVID-19 antibody begins nursing home trials
Novavax COVID vaccine produces antibodies in early-stage trials

Manufacturing
Moderna and J&J have disclosed vastly different price points for their lead COVID-19 vaccine candidates
State attorneys request that U.S. lowers price of remdesivir

That’s all for now. See you next week!

Joshua Neil, Editor
Proventa International

To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Biomanufacturing Strategy Meeting 2020.

More news

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 days ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 15/1/21

In the news this week, COVID vaccine production continues to advance, with Regeneron signing a new $2.6 billion deal in the US, the J&J one-shot looks set to distribute in March 2021, and two inhaler treatments advance in trials. In...

2 days ago

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

1 week ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 8/1/21

Vaccines dominate the news this week, as multiple companies come ever closer to having their products greenlit for market. Janssen’s single-shot vaccine could be approved within weeks, while Moderna’s vaccine sees EU take-up and AZ/Oxford University’s product seems set for...

1 week ago

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

4 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

How COVID-19 has Affected Clinical Operations

The COVID-19 pandemic has disrupted sectors and organisations around the world. But one of the most vital fields that has seen significant impact is in clinical operations. Trials and supply chains have had to be rapidly changed to accommodate the...

4 months ago
Working With us

Interested?
Reserve your space